| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Centre Experience
|
Kopińska, Anna
|
|
|
23 |
1 |
p. 28-39
|
artikel
|
| 2 |
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry
|
Góra-Tybor, Joanna
|
|
|
23 |
1 |
p. e19-e26
|
artikel
|
| 3 |
A Systematic Review on Second Treatment-Free Remission (TFR) Attempt in Chronic Myeloid Leukemia (CML): Can it be Applied in Clinical Practice?
|
Çiftçiler, Rafiye
|
|
|
23 |
1 |
p. 8-14
|
artikel
|
| 4 |
Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature
|
Asghar, Noureen
|
|
|
23 |
1 |
p. 15-21
|
artikel
|
| 5 |
Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving Anti-CD19 CAR T-cell Therapy
|
Jodon, Gray
|
|
|
23 |
1 |
p. 49-56
|
artikel
|
| 6 |
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
|
Schjesvold, Fredrik
|
|
|
23 |
1 |
p. e59-e70
|
artikel
|
| 7 |
Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS
|
Fu, Weijun
|
|
|
23 |
1 |
p. e51-e58
|
artikel
|
| 8 |
Early Intervention With a Curative Intent Through an Intensive Therapy Versus Immunologic Disease Control Using a Minimal Intensity Approach in the Management of High-risk Smoldering Multiple Myeloma: A Systematic Review of Evidence From Clinical Trials
|
Ojo, Ademola S.
|
|
|
23 |
1 |
p. e27-e40
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
23 |
1 |
p. A1-A2
|
artikel
|
| 10 |
Fever Characteristics and Impact on Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy
|
Davis, James A.
|
|
|
23 |
1 |
p. e14-e18
|
artikel
|
| 11 |
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study
|
Mato, Anthony R.
|
|
|
23 |
1 |
p. 57-67
|
artikel
|
| 12 |
Outcomes of Autologous Stem Cell Transplantation as a Consolidative Strategy for the Treatment of Primary and Isolated Secondary Central Nervous System Diffuse Large B Cell Lymphomas
|
Sahin, Ugur
|
|
|
23 |
1 |
p. e1-e13
|
artikel
|
| 13 |
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
|
Cohen, Adam D.
|
|
|
23 |
1 |
p. 68-77
|
artikel
|
| 14 |
Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma
|
Martin, Thomas
|
|
|
23 |
1 |
p. 22-27
|
artikel
|
| 15 |
Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study
|
Casulo, Carla
|
|
|
23 |
1 |
p. 40-48
|
artikel
|
| 16 |
SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia
|
Babakhanlou, Rodrick
|
|
|
23 |
1 |
p. 1-7
|
artikel
|
| 17 |
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma
|
Foureau, David M.
|
|
|
23 |
1 |
p. e41-e50
|
artikel
|
| 18 |
Table of Contents
|
|
|
|
23 |
1 |
p. A3-A5
|
artikel
|
Tijdschrift beschrijving